Dear Colleagues, I have a young female patient who is treated by her GI with Entyvio infusions q 4 weeks for IBD/colitis with reasonable control of her symptoms. However she has become more susceptible to viral infections which now are more severe. Would TA1 be useful in this situation to decrease frequency and severity of viral illness and not counteract colitis controlling effect of Entyvio ? Any experience in the field? Thank you, Leonid Gordin